ORMP (Oramed Pharmaceuticals) Earnings per share growth rate in current year
The volatility of annual earnings per share demonstrates the ecological vector of Oramed Pharmaceuticals (ORMP), which eliminates the use of needles and syringes. Business stability relies on the patented POD system that protects proteins in the gastrointestinal tract. Today, 245.60 expresses the current value of the metric, highlighting the company's potential for pricing power driven by high demand among diabetics for innovative capsules over injections.
Financial and market metric breakdowns for oramed.com (ORMP)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
All Debt to Shareholders' Equity Ratio Oramed Pharmaceuticals|ORMP - Long-Term Debt to Capital|Short-Term Debt to Capital Oramed Pharmaceuticals Inc.|ORMP - Company Debts|Debt to Book Value ORMP|ORMP - Company Long-Term Debts|Short-Term Debt Oramed Pharmaceuticals|Immediate Liquidity Ratio oramed.com
- net income and valuation multiples indicators:
ORMP - Net Income|Expected Net Income Oramed Pharmaceuticals|ORMP - Price to Earnings Ratio|Price to Expected Earnings Ratio Oramed Pharmaceuticals Inc.|ORMP - PEG Multiple|Business Value to Operating Income Before Depreciation ORMP|ORMP - Operating profit EBITDA|Net earnings per share (EPS TTM) Oramed Pharmaceuticals|ORMP - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months oramed.com|ORMP - Earnings per share growth in current year|Expected earnings per share growth for next year Oramed Pharmaceuticals
- revenue and sales proceeds data:
Basic company analysis:ORMP, Oramed Pharma
This indicator mathematically captures the dynamics of net profit per share, reflecting the efficiency of cash flow management. The metric measures the percentage deviation of current EPS from the previous year's value, uncovering hidden costs. For Oramed Pharmaceuticals (ORMP), this calculation is critical when scaling the development of oral insulin. By analyzing the annual growth of net profit per share in percentage terms on GURU.Markets, an investor assesses the financial stability of this biotech innovator.
Direct competitors
Haleon PLC - Earnings per share increase in current year|KVUE (Kenvue Corp) - Earnings growth in current year|Earnings per share growth rate in current year Verona Pharma Inc. VRNA|Earnings per share growth in current year Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Earnings per share increase in current year|Earnings per share growth in current year Amneal AMRX|Perrigo Company PLC (PRGO) - Earnings per share growth rate in current year|ALVO - Earnings per share growth in current year|Earnings per share increase in current year LQDA (Liquidia Inc.)|GLPG: Earnings growth in current year|anipharmaceuticals.com (ANIP) - Earnings growth in current year|Earnings per share growth in current year MannKind|Net earnings per share growth this year Amphastar Pharmaceuticals Inc (AMPH)|Earnings growth in current year PCRX|SPRY - Earnings per share growth rate in current year|Earnings growth in current year TBPH (Theravance Biopharma)|AQST: Earnings per share growth this year|SCPH: Net earnings per share growth this year|Earnings per share increase in current year TECX (Tectonic Therapeutic, Inc.)|Tonix Pharmaceuticals Inc. (TNXP) - Earnings per share growth in current year|Earnings per share trend in current year SXTC (China SXT Pharmaceuticals, Inc.)|EPRX (Eupraxia Pharmaceuticals, Inc.) - Earnings growth in current year|BHST: Earnings per share increase in current year|Earnings growth in current year EXOZ|Earnings growth in current year enterabio.com (ENTX)|Earnings per share growth in current year MindWalk HYFT|Earnings per share increase in current year ABVC|CPIX - Earnings per share growth in current year|quantumbiopharma.com (QNTM) - Net earnings per share growth this year|FGEN: Earnings growth in current year|Telomir Pharmaceuticals Inc (TELO) - Earnings growth in current year|RANI (Rani Therapeutics Holdings) - Earnings growth in current year|Net earnings per share growth this year Synergy CHC Corporation (SNYR)|Earnings growth in current year RLYB|LEXX - Earnings per share growth rate in current year|Pulmatrix - Net earnings per share growth this year|Earnings growth in current year Pheton Holdings Limited PTHL|APM: Net earnings per share growth this year|Lyra Therapeutics Inc - Net earnings per one share growth for the current year|IBO: Earnings growth in current year|TNFA - Expected net earnings per share growth this year|YCBD (cbdMD Inc.) - Earnings growth in current year|Net earnings per share growth this year PainReform Ltd (PRFX)|Earnings growth in current year CYTO|Earnings growth in current year Lipella Pharma (LIPO)|Earnings per share growth in current year OptiNose, Inc. OPTN|pieris.com - Earnings per share growth in current year|PROC - Earnings per share growth in current year|Expected net earnings per share growth this year Petros Pharmaceuticals Inc PTPI|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|Earnings per share growth rate in current year ACELYRIN Inc. (SLRN)|Earnings per share growth in current year TFF Pharmaceuticals
